Status:
RECRUITING
Non-invasive Evaluation of the Predictive Value of CEUS and SWE in ACLF, Renal Failure and Hepatorenal Syndrome
Lead Sponsor:
University Hospital, Bonn
Conditions:
Kidney Failure, Acute
Eligibility:
All Genders
18-100 years
Brief Summary
Evaluation of non-invasive prognostic parameters in patients developing ACLF and renal failure in patients receiving and not receiving transjugular intrahepatic portosystemic shunt (TIPS). Patients ar...
Detailed Description
NECTAR consists of patients with ACLF and renal failure with and without receiving transjugular intrahepatic portosystemic shunt (TIPS) at the Department of Internal Medicine I, University of Bonn, Ge...
Eligibility Criteria
Inclusion
- All patients with portal hypertension and kidney failure
Exclusion
- no consent, no kidney failure, no portal hypertension
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2030
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04446858
Start Date
January 1 2021
End Date
July 1 2030
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Bonn
Bonn, Germany